Table I.
Simulation model inputs
| Probabilities | Rate/Cost | Sensitivity | Source |
|---|---|---|---|
| Contract COVID-19 | 5% | 2%-40% | Johns Hopkins University Coronavirus Resource Center,1 United States Census Bureau27 |
| Symptomatic COVID | 60% | 30%-90% | Centers for Disease Control and Prevention28 |
| COVID hospitalization if symptomatic | 6% | 5%-30% | Centers for Disease Control and Prevention29 |
| COVID-19 fatality | 2% | 1%-10% | Johns Hopkins University Coronavirus Resource Center1 |
| Risk-stratification vaccine deferral | 5% | 1%-20% | Wood et al30 |
| COVID vaccine anaphylaxis | 0.1% | 0.0%-1% | 2 |
| Anaphylaxis hospitalization | 22% | 10%-30% | Clark et al31 |
| Anaphylaxis case-fatality | 0.33% | 0.1%-0.5% | Ma et al32 |
| Vaccine protection from COVID | 95% | 90%-99% | 2 |
| Anaphylaxis hospitalization | $21,897 | $5,000-$25,000 | Candrilli and Kurosky,33 US Department of Labor, Bureau of Labor Statistics34 |
| COVID Hospitalization | $73,300 | $25,000-$100,000 | 35 |
| Risk-stratification anaphylaxis protection | 95% | 90%-99% | Assumption |